Chemotherapy for high-grade glioma (Q34169384)

31 July 2017

0 references

1 reference

title

Chemotherapy for high-grade glioma. (English)

1 reference

31 July 2017

1 reference

Glioma Meta-Analysis Trialists (GMT) Group

series ordinal

1

1 reference

31 July 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

published in

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

CD003913

1 reference

Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Adjuvant nitrosourea therapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Controlled study of CCNU and radiation therapy in malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Effects of ACNU and radiotherapy on malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

The existence of publication bias and risk factors for its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003913

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0014-2964(78)90100-7

Identifiers

DOI

10.1002/14651858.CD003913

1 reference

31 July 2017

1 reference